Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

UK Vaccination Rate Slows Down On Shortage Of Pfizer Jabs

06/16/2021 | 07:49am EDT


ę MT Newswires 2021
All news about PFIZER, INC.
03:41aPFIZER : CMA accuses pharma firms Pfizer and Flynn of charging NHS illegal price..
AQ
02:49aPfizer epilepsy drug prices were 'unfairly high,' UK review finds
RE
02:49aPFIZER : We'd rather share the vaccine supply, not the Covid virus, says Manches..
AQ
02:33aBRITISH COMPETITION WATCHDOG : Pfizer, Flynn Pharma Overcharged NHS for Anti-Epi..
MT
02:19aAnalysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
RE
01:33aU.S. COVID-19 cases hit six-month high at over 100,000 ľ Reuters tally
RE
12:54aPfizer Accused of Overcharging for Epilepsy Seizure Drug by UK Competition Wa..
DJ
12:08aPFIZER : to Require COVID-19 Shots or Regular Testing for US Workers
MT
08/04FACTBOX : Major U.S. companies making masks, vaccines mandatory
RE
08/04ALPHABET : Pfizer to require U.S. workers receive COVID-19 vaccine or regular te..
RE
More news
Financials (USD)
Sales 2021 79 586 M - -
Net income 2021 18 722 M - -
Net Debt 2021 26 885 M - -
P/E ratio 2021 13,1x
Yield 2021 3,49%
Capitalization 253 B 253 B -
EV / Sales 2021 3,52x
EV / Sales 2022 4,25x
Nbr of Employees 78 500
Free-Float 59,2%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 24
Last Close Price 45,19 $
Average target price 43,82 $
Spread / Average Target -3,03%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.22.77%252 960
JOHNSON & JOHNSON10.15%459 079
ROCHE HOLDING AG14.16%340 492
ELI LILLY AND COMPANY55.45%232 701
NOVARTIS AG-0.20%224 638
NOVO NORDISK A/S36.67%213 138